Results 91 to 100 of about 3,314 (195)

Impact of demographic and clinical factors on elagolix plus add-back therapy effects on patient-reported nonbleeding symptoms in women with heavy menstrual bleeding and uterine fibroids: a post hoc analysis of data from two clinical trials

open access: yesF&S Reports
Objective: To investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) across ...
James A. Simon, M.D.   +4 more
doaj   +1 more source

Norethindrone Acetate Enhances the Antiatherogenic Effect of 17β-Estradiol

open access: yes, 1998
—The influence of progestogens in combination with 17β-estradiol (E2) on cardiovascular disease remains controversial. This study investigated the effect of norethindrone acetate (NETA) combined with E2 on aortic atherosclerosis.
Irene Sandholdt   +5 more
core   +1 more source

Comparison of Dermatologic and Neuropsychological Side Effects of Oral Contraceptives, 2016-2020. [PDF]

open access: yesOpen Access J Contracept
Visingardi J   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy